Related Experiment Video
Updated: Jul 15, 2026

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
Published on: August 21, 2016
Genetic variants underpinning lung function decline in the Lifelines general population cohort study
Rui Marçalo1,2,3,4, Corry-Anke Brandsma4,5, Peter J van der Most6
1Genome Medicine Lab, Institute of Biomedicine (iBiMED), Department of Medical Sciences, University of Aveiro, Aveiro, Portugal.
Rationale:
Variations in age-related lung function decline are associated with genetic and environmental factors. The genetic variants contributing to this decline remain largely unknown, limiting the understanding of individual susceptibility and potential interventions. This study aims to uncover the genetic factors associated with lung function decline, using the Lifelines cohort study.
Methods:
Longitudinal data covering three visits over approximately 15 years were available. Genotyping and longitudinal spirometry data were present for 24 749 subjects aged 25 years or older at baseline. A three-step approach was used. First, lung function change over time was estimated using a linear mixed-effects model. Second, a genome-wide association study for the estimated change was conducted, adjusting for age, sex, smoking load and the first 10 principal components. Third, single-nucleotide polymorphisms (SNPs) with p-value<1×10-5 were analysed using a linear mixed-effects model. Selected SNPs were tested in two independent cohorts (n=1376 and n=27 249), followed by meta-analysis.
Measurements And Main Results:
Among the included individuals, 19 722 had spirometry at two time points and 5027 at three, with median (IQR) follow-up of 8.1 (4.4-10.4) and 12.1 (11-13.6) years, respectively. We identified 67 variants suggestively associated with lung function decline (p<1×10-5). Rs150094594, was significant (p=0.007) in a replication cohort with consistent effect direction. This intergenic variant, not previously reported, reached genome-wide significance in the meta-analysis (rs150094594:T, β (se): 15.9 (2.7) mL·y-1, p-value=3.9×10-9).
Conclusions:
This study shows a role of genetics in lung function decline, emphasising the importance of exploring the interplay between genetic and environmental factors.
Related Concept Videos
Principles of Pharmacogenetics: Types of Genetic Variants
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Single Nucleotide Polymorphisms-SNPs
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...